Zio­phar­m's ac­tivist dra­ma con­tin­ues as an­oth­er board mem­ber mem­ber re­signs. Is the end in sight?

The very pub­lic and very bit­ter fight be­tween Zio­pharm On­col­o­gy and a mi­nor­i­ty ac­tivist in­vestor con­tin­ued Fri­day with the res­ig­na­tion of a board mem­ber to whom the lat­ter had ob­ject­ed.

In a let­ter to share­hold­ers sent Fri­day morn­ing, Zio­pharm an­nounced it had ac­cept­ed the res­ig­na­tion of Elan Ez­ick­son, fol­low­ing calls to re­place him from 3.3% stake­hold­er Wa­ter­Mill As­set Man­age­ment Corp. Zio­pharm has not an­nounced a re­place­ment and it re­mains to be seen if they will, ef­fec­tive­ly shrink­ing the board to sev­en for the time be­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER